Plasma and Urine Indoleamine 2,3-Dioxygenase Activity: Promising Biomarkers for Chronic Kidney Disease and Inflammation Status

Plasma and Urine Indoleamine 2,3-Dioxygenase Activity: Promising Biomarkers for Chronic Kidney Disease and Inflammation Status

Hao Hong,1 Suya Zhou,2 Haimin Shi,3 Ming Li3 1Intensive Care Unit, The First Affiliated Hospital of Soochow University, Soochow, People’s Republic of China; 2Laboratory Nephrology, Department of Nephrology, Jinshan Hospital of Fudan University, Shanghai, People’s Republic of China; 3Laboratory Nephr...

Full description

Bibliographic Details
Main Authors:	Hong H, Zhou S, Shi H, Li M
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-09-01
Series:	Journal of Inflammation Research
Subjects:	tryptophan rate-limiting enzyme inflammatory hs-crp liquid chromatography-mass spectrometry
Online Access:	https://www.dovepress.com/plasma-and-urine-indoleamine-23-dioxygenase-activity-promising-biomark-peer-reviewed-fulltext-article-JIR

Similar Items

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
by: Peng X, et al.
Published: (2022-08-01)

Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy
by: Ning Deng, et al.
Published: (2021-02-01)

Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice
by: Maria J. Forteza, et al.
Published: (2018-05-01)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017-07-01)

Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
by: Corina Bello, et al.
Published: (2021-11-01)

The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
by: Knut A. Hestad, et al.
Published: (2017-10-01)

Threshold effect and sex characteristics of the relationship between chronic inflammation and BMI
by: Su Liqiang, et al.
Published: (2023-08-01)

Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression
by: Karl Savonije, et al.
Published: (2023-05-01)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
by: Camilla Grønkjær Jensen, et al.
Published: (2021-07-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
by: Mona F.M El-Karn, et al.
Published: (2016-01-01)

Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren’s Syndrome in SATB1-Conditional Knockout Mice
by: Yuriko Tanaka, et al.
Published: (2021-09-01)

<i>Indoleamine 2,3-Dioxygenase 2</i> Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation
by: Kento Fujii, et al.
Published: (2020-08-01)

High-sensitivity C-reactive protein as biomarker of inflammation in children with asthma and allergic rhinitis
by: Dragana Malčić-Zanić, et al.
Published: (2018-12-01)

Status of indoleamine-2,3-dioxygenase 1 in infiltrating ductal carcinoma of breast cancer: a new prognostic indicator for aggressive tumors
by: T. Salmi, et al.
Published: (2021-09-01)

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
by: Jacques C. Mbongue, et al.
Published: (2015-09-01)

Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
by: Ute F. Röhrig, et al.
Published: (2022-12-01)

Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents
by: Hui Wen, et al.
Published: (2019-06-01)

A Multifaceted Role of Tryptophan Metabolism and Indoleamine 2,3-Dioxygenase Activity in Aspergillus fumigatus–Host Interactions
by: Tsokyi Choera, et al.
Published: (2018-01-01)

Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients
by: Tingming Cao, et al.
Published: (2022-01-01)

Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer
by: Dyah L. Dewi, et al.
Published: (2017-02-01)

Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults
by: Niknaz Riazati, et al.
Published: (2022-09-01)

The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus
by: Abram DM, et al.
Published: (2017-07-01)

The impact of smoking on inflammatory biomarkers in patients with chronic obstructive pulmonary disease
by: Yasser A. Korani, et al.
Published: (2016-07-01)

Comparison of inflammation and oxidative stress levels by the severity of obesity in prepubertal children
by: Ni Luh Putu Surya Candra Eka Pertiwi, et al.
Published: (2018-01-01)

Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: a case-control study
by: Luukkainen Annika, et al.
Published: (2011-12-01)

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
by: Asha Nayak-Kapoor, et al.
Published: (2018-06-01)

Biomarkers of chronic inflammation and cognitive decline: A prospective observational study
by: Bhavna A. Guduguntla, et al.
Published: (2024-01-01)

Assessment of High Sensitivity C.Reactive Protein in male patients with metabolic syndrome and atherosclerosis complications
by: Faris Abdul Kareem Khazaal, et al.
Published: (2012-12-01)

High-Sensitivity C-Reactive Protein, Its Change, and Cognitive Function: A National Population-Based Cohort Study
by: Yechuang Wang, et al.
Published: (2023-04-01)

Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase 1 Influenced the Age Onset of Parkinson's Disease
by: Nóra Török, et al.
Published: (2022-09-01)

Kuqin ameliorates Lipopolysaccharide-induced acute lung injury by regulating indoleamine 2,3-dioxygenase 1 and Akkermansia muciniphila
by: Shihui Xiong, et al.
Published: (2023-02-01)

Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
by: Yvonne Grobben, et al.
Published: (2021-01-01)

Macronutrients, micronutrients intake and inflammation in hemodialysis patients
by: Siti Fatonah, et al.
Published: (2019-11-01)

Effect of curcumin on inflammatory biomarkers and iron profile in patients with premenstrual syndrome and dysmenorrhea: A randomized controlled trial
by: Amir Talebpour, et al.
Published: (2023-07-01)

What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
by: Yu Yao, et al.
Published: (2021-02-01)

Synthesis and Molecular Modeling Studies of N′-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
by: Dong-Ho Lee, et al.
Published: (2017-11-01)

Serum indoleamine 2,3-dioxygenase level and diagnostic value in patients with rosacea
by: Merve Sena Odabasi, et al.
Published: (2023-01-01)

Indoleamine 2,3-dioxygenase in endometriosis
by: Hui-Li Yang, et al.
Published: (2019-01-01)

Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
by: Ying Tan, et al.
Published: (2022-11-01)

MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1
by: Wentao Zhang, et al.
Published: (2019-07-01)